V8 Peptides — Engineered Performance
Research Library
BPC-157 Reconstitution and Storage: A Lab Protocol
BPC-157Reconstitution & Handling

BPC-157 Reconstitution and Storage: A Lab Protocol

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What is the correct lab protocol for reconstituting and storing BPC-157? Equilibrate the sealed vial to room temperature, fix the target stock concentration first, then compute the diluent volume as V = m ÷ c. Run the diluent down the glass wall, swirl without shaking, inspect for clarity, label, and either hold the stock cold or freeze single-use aliquots. Store sealed powder at 2–8 °C near-term and −20 °C long-term, away from heat, moisture and light. Do all arithmetic with the reconstitution calculator and record every step.

A 10 mg vial of BPC-157 is a small, dry, simple-looking object, but most of the variability that later shows up in an assay is introduced in the first ten minutes after the vial is opened. This guide is written as a bench protocol: an ordered sequence of checks and handling steps for reconstituting and storing lyophilized BPC-157 in a research laboratory, with the chemistry behind each step. It complements the broader BPC-157 research overview and the general method in how to reconstitute a lyophilized peptide. The compound is supplied for laboratory research use only; nothing here describes use in people or animals outside an approved research protocol.

Know what is in the vial before opening it

The BPC-157 product page lists a single 10 mg size, supplied as lyophilized powder in a sealed clear glass research vial, with purity stated as ≥98% by HPLC and storage given as 2–8 °C for near-term holding and −20 °C for long-term holding, protected from heat, moisture and light. The sequence is the fifteen-residue chain Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. From the sequence the molecular formula works out to C62H98N16O22, an average mass near 1419.5 Da, which agrees with the 1419 value reported in the original tendon papers.

Two features of that sequence shape handling. First, it is proline-rich, with a run of three prolines near the N-terminus and two more further along, which keeps the chain flexible and unstructured in solution rather than folding into a compact domain that would need protecting. Second, it contains two adjacent aspartic acid residues and one glutamic acid, so it is an acidic peptide with a free N-terminal glycine and a free C-terminal valine; its solubility in plain water is generally unremarkable, and aggregation is not the main concern that it is for lipidated peptides. The practical risks are chemical (slow Asp-related isomerization and oxidation of trace contaminants) and physical (adsorption to surfaces at low concentration).

PropertyValue used in this guideSource
Supplied formLyophilized powder, 10 mg per vialProduct page
Purity specification≥98% by HPLCProduct page
SequenceGEPPPGKPADDAGLV (15 residues)Product page
Formula / average massC62H98N16O22 / about 1419.5 g/molCalculated from the sequence
Storage2–8 °C near-term; −20 °C long-term; protect from heat, moisture and lightProduct page
ContainerSealed clear glass vial (no light protection of its own)Product page

Before the seal is broken, match the lot number on the vial with the entry in the COA library and write both into the notebook. A certificate is listed where one has been published for the lot; how to read a COA explains what each field does and does not establish.

The reconstitution protocol, step by step

The steps below are the order that protects the peptide and the record. None of them is exotic; the value is in doing them the same way every time.

  1. Equilibrate. Move the sealed vial from the refrigerator or freezer to the bench and let it reach room temperature unopened. Opening a cold vial pulls humid air onto a hygroscopic solid, and the water that condenses starts the degradation you were trying to avoid.
  2. Inspect and photograph. A freeze-dried cake is white to off-white, sometimes broken or loose. A wet, glassy, collapsed or discolored solid is a reason to log the observation before going further. What is normal in a peptide vial describes the range.
  3. Choose the solvent first. Decide on the diluent from the assay, not from habit. Bacteriostatic water carries a preservative and suits a stock vial that will be entered several times; sterile water suits a stock that will be divided and frozen at once, or an assay where benzyl alcohol would interfere. Bacteriostatic water explained covers the trade-offs, and the product is listed as bacteriostatic water, 10 ml.
  4. Fix the target concentration, then derive the volume. Write the target stock concentration in the notebook before touching a syringe, and compute the diluent volume from it (formula in the next section). Doing it in this order prevents the common error of adding a convenient volume and then back-calculating a concentration nobody wanted.
  5. Add the diluent gently. Run it down the inner glass wall rather than onto the cake. Do not shake or vortex. Swirl slowly or rock the vial and allow standing time; a short peptide dissolves quickly, and foam only adds interface area for adsorption and oxidation.
  6. Check the solution. It should be clear and colorless with no particles, strands or haze. Anything else is documented rather than ignored; cloudy peptide vial after reconstitution lists likely causes.
  7. Label and log. Compound, lot, concentration, solvent, date, time, operator and storage location go on the vial and in the notebook.
  8. Aliquot or hold. Either keep the working stock refrigerated and use it within the window set by your own stability data, or divide it into single-use portions in low-binding tubes and freeze them straight away.

Concentration arithmetic as a formula

This site does not publish per-product tables of volumes, because the right volume depends on the stock concentration an experiment needs. The arithmetic is short enough to do by hand, and the reconstitution calculator performs it and keeps the units straight. The relationships are:

QuantityFormulaNotes
Mass concentrationc (mg/mL) = m (mg) ÷ V (mL)m is the labeled vial mass; V is the added diluent volume
Diluent volume for a targetV (mL) = m (mg) ÷ c (mg/mL)Fix c first, then compute V
Molar concentrationc (mol/L) = [m (mg) ÷ MW (g/mol)] ÷ V (mL)Use MW ≈ 1419.5 g/mol for BPC-157
Serial dilutionC1 × V1 = C2 × V2Dilute from stock immediately before use
Net peptide correctionm(active) = m(labeled) × net peptide fractionOnly when a net peptide content figure is available

Two caveats belong next to any calculation. The labeled mass is the lyophilized solid, which also contains counterions and residual water, so the true peptide content is below the labeled mass by an amount that purity by HPLC does not report. HPLC purity expresses the share of the chromatographic peak area belonging to the target sequence, not the share of the powder. The effect on a stock concentration is usually a few percent to a few tens of percent, and if the assay is concentration-critical, the stock should be quantified (for example by amino acid analysis or a validated chromatographic standard) rather than trusted from arithmetic alone. Second, adding diluent changes the final volume slightly; at stock volumes of a millilitre or more the error is negligible, but in small volumes it should be considered. For a worked method see peptide reconstitution volume calculations and the reconstitution calculator guide.

Storage tiers and what drives degradation

Storage guidance for a lyophilized peptide follows from three degradation routes: hydrolysis and deamidation or isomerization in the presence of water, oxidation, and physical loss. General reviews of peptide and protein stability (Manning et al., 2010; Wang, 1999) describe all three, and the older work of Geiger and Clarke (1987) established that aspartyl residues can isomerize through a cyclic succinimide intermediate, at a rate that depends strongly on the neighboring residue. BPC-157 contains an Asp-Asp pair followed by Ala-Gly, so slow aspartyl chemistry is a plausible degradation route in solution over long times, which is one reason time in solution is kept short.

StateTypical holding conditionWhat it protects against
Sealed lyophilized vial, near-term2–8 °C, dry, darkMoisture uptake, heat, light
Sealed lyophilized vial, long-term−20 °C, dry, darkSlow solid-state chemistry
Reconstituted stock in use2–8 °C, tightly capped, minimal entriesMicrobial growth (with preservative), thermal chemistry
Single-use aliquots−20 °C, low-binding tubes, thawed onceRepeated freeze–thaw stress, repeated vial entries
Working dilutionPrepared immediately before the assayAdsorption loss at low concentration

No validated shelf life has been published for research-grade BPC-157 reconstituted in bacteriostatic or sterile water, so any number quoted without data should be treated as folklore. The honest answer is to define an acceptance criterion, such as peak area by HPLC against a freshly prepared reference within an agreed tolerance, and to measure. Cox and colleagues (2017) reported that BPC-157 was stable in urine for at least four days in their LC-MS work, which says something about the peptide backbone but nothing about a laboratory stock in water. The related guides how long reconstituted peptides last, storing research peptides and BPC-157 room-temperature stability go deeper on the time question.

Freeze–thaw, adsorption and other bench traps

Freezing is not neutral. As ice forms, solutes and peptide concentrate in the unfrozen fraction, pH can shift, and ice-liquid interfaces appear; Bhatnagar and colleagues (2007) separate these stresses in their review of protein stability during freezing. A short linear peptide is far less fragile than a protein, but repeated cycles still add uncontrolled variables. Plan for one thaw per aliquot.

Adsorption is the quieter problem. Peptides stick to polypropylene and glass, and the fractional loss is largest in dilute solutions, so a 10 µM working dilution can lose a meaningful share of its content to the tube wall before it reaches the cells. Goebel-Stengel and co-workers (2011) compared plasticware and glassware for peptide work and found that the choice of material changes recovery substantially. Low-binding tubes and tips, fewer transfers and dilution immediately before use keep the loss small. A carrier protein in the assay buffer is another common remedy where the assay allows it.

Other traps are mundane: multiple needle entries into one stock vial, solvent evaporation through a worn stopper, labels that rub off in the freezer, and aliquot boxes that are not mapped. A one-page storage map, listing the position of each aliquot, costs minutes and saves lots.

Documentation that makes the work repeatable

A reconstitution record has to let a stranger reproduce the stock. Capture the lot number and COA reference, the solvent and its own lot and expiry, the target and achieved concentration with the formula used, the diluent volume, the date and time, the operator, the visual appearance of the vial and of the solution, and where each aliquot is stored. Add every thaw as a dated entry. If the stock is later checked by HPLC, file the chromatogram beside the record; understanding HPLC purity explains what a purity trace shows and what it cannot.

Record fieldWhy it is recorded
Vial lot and COA referenceTies the stock to analytical documentation where it is published
Diluent type, lot, expiryA preservative or a different water changes assay conditions
Target and calculated concentrationShows the arithmetic was done before the vial was opened
Appearance before and afterEarly warning for moisture damage or aggregation
Aliquot map and thaw logMakes repeated freeze–thaw visible
Operator and dateAllows deviations to be traced

If the stock will be combined with other peptides, handle that as a separate documented step; the blend considerations are covered in BPC-157 and TB-500 blend reconstitution, and the compound-specific background is in BPC-157 purity testing. All materials discussed here are for laboratory research use only.

Frequently asked questions

How should lyophilized BPC-157 be stored before reconstitution?

The product page states 2–8 °C for near-term holding and −20 °C for long-term holding, protected from heat, moisture and light. The clear glass vial gives no light protection by itself, so keep it in its box or wrap it in foil.

Why let the vial warm to room temperature before opening?

A cold vial draws humid air onto the dry cake, and condensed water starts hydrolysis and clumping. Waiting until the vial reaches room temperature while still sealed avoids that.

Bacteriostatic water or sterile water for BPC-157?

Bacteriostatic water suits a stock vial that will be entered more than once because the preservative limits microbial growth. Sterile water suits a stock that is divided and frozen the same day, or an assay where benzyl alcohol would interfere.

How is the diluent volume worked out?

Choose the stock concentration the experiment needs, then divide the labeled vial mass by that concentration: V (mL) = m (mg) ÷ c (mg/mL). The reconstitution calculator on this site does the arithmetic and units.

Why should BPC-157 not be shaken?

Shaking creates foam and air–water interfaces, which promote adsorption and oxidation without helping dissolution. Slow swirling plus standing time is gentler and just as fast for a short peptide.

How long does reconstituted BPC-157 last?

No validated shelf life has been published for research-grade BPC-157 in bacteriostatic or sterile water. Keep the stock cold, limit time in solution, freeze single-use portions for longer work and confirm concentration by HPLC where it matters.

How many freeze–thaw cycles can a BPC-157 stock take?

Plan for one thaw per aliquot. Freezing concentrates solutes and creates ice interfaces, and each cycle adds variables that are hard to control.

Does HPLC purity tell me the peptide content of the vial?

No. HPLC purity is the share of chromatographic peak area belonging to the target sequence. Counterions and residual water also occupy mass, so the net peptide content is lower than the labeled mass.

What should a clear, properly reconstituted solution look like?

Clear and colorless, without particles, strands or lasting foam. Haze or visible material should be documented and the stock set aside until it is understood.

Why use low-binding tubes for dilute BPC-157 solutions?

Peptides adsorb to plastic and glass, and the fractional loss is greatest at low concentration. Low-binding consumables and dilution just before use reduce the loss.

Related reading: BPC-157 Preclinical Study Design and Reported Parameters, BPC-157 Preclinical Safety Profile: What Studies Report, BPC-157 Tendon Research: Rat and Cell Studies Explained.

References

  1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  2. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
  3. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. PMID: 3805008
  4. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
  5. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
  6. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H by LC-MS/MS. Drug Test Anal. 2017;9(10):1490-1498. doi:10.1002/dta.2152
  7. Staresinic M, Petrovic I, Novinscak T, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. doi:10.1016/S0736-0266(03)00110-4

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.